W
CMD

Wealthfront’s Cantel Medical Corporation CMD Stock Holding History

Wealthfront’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-253
Closed -$14K – 1182
2015
Q3 		$14K Buy
253
+226
+837% +$12K ﹤0.01% 868
2015
Q2 		$1K Buy
27
+17
+170% +$827 ﹤0.01% 1270
2015
Q1 		$0 Buy
+10
New +$443 ﹤0.01% 1275

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wealthfront's CMD Position: Q4 2015 in Review

Wealthfront sold out of Cantel Medical Corporation (CMD) in Q4 2015, closing a stake of 253 shares — an estimated $14K sold.

Wealthfront first reported a position in CMD in Q1 2015 and held it in 3 quarters. The position peaked at $14K in Q3 2015. 201 funds tracked by Wall St. Rank hold CMD as of Q4 2015.

  • Wealthfront reported no remaining Cantel Medical Corporation position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 253 Cantel Medical Corporation shares in Q4 2015, an estimated $14K.
  • Wealthfront first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 3 quarters.
  • Wealthfront's Cantel Medical Corporation position peaked at $14K in Q3 2015.
  • 201 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.